Novavax, Inc. (NVAX)
12.75
+1.74
(+15.80%)
USD |
NASDAQ |
Oct 09, 16:00
12.70
-0.05
(-0.39%)
After-Hours: 20:00
Novavax Free Cash Flow (Quarterly) : -73.40M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -73.40M |
| March 31, 2026 | -33.69M |
| December 31, 2025 | -41.72M |
| September 30, 2025 | 105.79M |
| June 30, 2025 | -127.99M |
| March 31, 2025 | -187.10M |
| December 31, 2024 | -175.42M |
| September 30, 2024 | -146.83M |
| June 30, 2024 | 311.14M |
| March 31, 2024 | -90.80M |
| December 31, 2023 | -185.86M |
| September 30, 2023 | -58.05M |
| June 30, 2023 | -179.72M |
| March 31, 2023 | -352.74M |
| December 31, 2022 | -139.88M |
| September 30, 2022 | -68.23M |
| June 30, 2022 | -195.48M |
| March 31, 2022 | -105.34M |
| December 31, 2021 | -358.77M |
| September 30, 2021 | -154.33M |
| June 30, 2021 | 129.26M |
| March 31, 2021 | 649.30M |
| December 31, 2020 | -170.58M |
| September 30, 2020 | -15.22M |
| June 30, 2020 | 111.87M |
| Date | Value |
|---|---|
| March 31, 2020 | -23.23M |
| December 31, 2019 | -23.96M |
| September 30, 2019 | -32.62M |
| June 30, 2019 | -30.49M |
| March 31, 2019 | -51.41M |
| December 31, 2018 | -45.78M |
| September 30, 2018 | -33.91M |
| June 30, 2018 | -40.28M |
| March 31, 2018 | -66.22M |
| December 31, 2017 | -36.18M |
| September 30, 2017 | -45.40M |
| June 30, 2017 | -13.64M |
| March 31, 2017 | -45.58M |
| December 31, 2016 | -62.77M |
| September 30, 2016 | -68.93M |
| June 30, 2016 | -68.65M |
| March 31, 2016 | -76.63M |
| December 31, 2015 | -22.89M |
| September 30, 2015 | -32.94M |
| June 30, 2015 | -16.70M |
| March 31, 2015 | -35.65M |
| December 31, 2014 | -21.86M |
| September 30, 2014 | -19.11M |
| June 30, 2014 | -12.03M |
| March 31, 2014 | -22.40M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Moderna, Inc. | -563.00M |
| Merck & Co., Inc. | 4.477B |
| Pfizer Inc. | 302.00M |
| Agenus, Inc. | -31.20M |
| Editas Medicine, Inc. | -29.67M |